What preliminary studies are supporting the concept of bioactive cements?
Nicolas AMORETTI
Can you present the challenges of the AROME session?
Yazid BELKACEMI
Oncologist-Radiotherapist, Créteil, France
What are the opportunities brought by the BCU and what are the contributions of genetics to the management of breast cancer?
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
Therapeutic options and systemic therapy.
Joseph GLIGOROV
Oncologist, Paris, France
Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France